Prevention of OHSS: Current strategies and new insights

被引:9
作者
Busso, Cristiano [1 ]
Antonio Garcia-Velasco, Juan [2 ]
Simon, Carlos [3 ]
Pellicer, Antonio [3 ]
机构
[1] Univ Valencia, Valencia 46010, Spain
[2] Inst Valenciano Infertilidad, Madrid, Spain
[3] IVI Valencia, Plaza Policia Local 3, Valencia, Spain
关键词
ART; OHSS; Prevention; Dopamine agonists;
D O I
10.1016/j.mefs.2010.06.013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic and potentially life threatening condition that affects young healthy patients. Many strategies have been proposed to prevent this syndrome. However, to avoid OHSS without compromising on IVF outcome is still a challenge. The most important action is to identify patients at risk even before ovarian stimulation is initiated and to give them special attention. Coasting is the most popular method to avoid/minimize OHSS. Cycle cancellation, cryopreservation, GnRH antagonists, GnRH agonists, i.v. albumin are other strategies that can provide some kind of benefit but do not completely avoid both early and late forms of OHSS and/or cannot be applied to every patient. Recent studies demonstrate that dopamine agonists can prevent or minimize OHSS without affecting IVF outcome but clinical protocols are not well established yet. (C) 2010 Middle East Fertility Society. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 84 条
[1]   Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review [J].
Aboulghar, M ;
Evers, JH ;
Al-Inany, H .
HUMAN REPRODUCTION, 2002, 17 (12) :3027-3032
[2]   A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS [J].
Aboulghar, Mohamed A. ;
Mansour, Ragaa T. ;
Amin, Yahia M. ;
Al-Inany, Hesham G. ;
Aboulghar, Mona M. ;
Serour, Gamal I. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 15 (03) :271-279
[3]   An 'epidemic' of severe OHSS: a price we have to pay? [J].
Abramov, Y ;
Elchalal, U ;
Schenker, JG .
HUMAN REPRODUCTION, 1999, 14 (09) :2181-2183
[4]   Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates [J].
Acevedo, Belen ;
Gomez-Palomares, Jose Luis ;
Ricciarelli, Elisabetta ;
Hernandez, Eleuterio R. .
FERTILITY AND STERILITY, 2006, 86 (06) :1682-1687
[5]   Three years of routine vitrification of human zygotes: is it still fair to advocate slow-rate freezing? [J].
Al-Hasani, Safaa ;
Ozmen, Batuhan ;
Koutlaki, Nikoleta ;
Schoepper, Beate ;
Diedrich, Klaus ;
Schultze-Mosgau, Askan .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 14 (03) :288-293
[6]   GnRH antagonist in assisted reproduction: a Cochrane review [J].
Al-Inany, H ;
Aboulghar, M .
HUMAN REPRODUCTION, 2002, 17 (04) :874-885
[7]   Gonadotrophin-releasing hormone antagonists for assisted conception: A Cochrane Review [J].
Al-Inany, H. G. ;
Abou-Setta, A. M. ;
Aboulghar, M. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 14 (05) :640-649
[8]   Ovarian stimulation with HMG:: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin [J].
Albano, C ;
Felberbaum, RE ;
Smitz, J ;
Riethmüller-Winzen, H ;
Engel, J ;
Diedrich, K ;
Devroey, P .
HUMAN REPRODUCTION, 2000, 15 (03) :526-531
[9]   Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment:: a pilot study [J].
Alvarez, Claudio ;
Alonso-Muriel, Isabel ;
Garcia, Gabriela ;
Crespo, Juana ;
Bellver, Jose ;
Simon, Carlos ;
Pellicer, Antonio .
HUMAN REPRODUCTION, 2007, 22 (12) :3210-3214
[10]   Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction [J].
Alvarez, Claudio ;
Marti-Bonmati, Luis ;
Novella-Maestre, Edurne ;
Sanz, Roberto ;
Gomez, Raul ;
Fernandez-Sanchez, Manuel ;
Simon, Carlos ;
Pellicer, Antonio .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08) :2931-2937